Predictive values of procalcitonin for coinfections in patients with COVID-19 : a systematic review and meta-analysis
© 2023. The Author(s)..
OBJECTIVES: To assess the ability of procalcitonin (PCT)-a promising marker for coinfections-to predict coinfections in patients with COVID-19.
METHODS: In this systematic review and meta-analysis, PubMed, Embase, Web of Science, Cochrane, the China National Knowledge Infrastructure (CNKI), and Wanfang were searched to identify eligible studies (up to August 30, 2021). Articles that reported the predictive value of PCT for coinfections in patients with COVID-19 were included. Individual and pooled sensitivities and specificities were reported, and I2 was used to test heterogeneity. This study was prospectively registered on the International Prospective Register of Systematic Reviews (PROSPERO) database (registration number: CRD42021283344).
RESULTS: Five studies involving a total of 2775 patients reported the predictive value of PCT for coinfections in patients with COVID-19. The sensitivity, specificity, and area under the curve of PCT in predicting coinfections in the pooled studies were 0.60 (95% CI 0.35-0.81, I2 = 88.85), 0.71 (95% CI 0.58-0.81, I2 = 87.82), and 0.72(95% CI 0.68-0.76) respectively.
CONCLUSIONS: Although PCT has limited predictive value for coinfections in patients with COVID-19, lower PCT levels seem to indicate a decreased probability of having a coinfection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Virology journal - 20(2023), 1 vom: 08. Mai, Seite 92 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wei, Shanchen [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 11.05.2023 Date Revised 20.06.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12985-023-02042-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356620034 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356620034 | ||
003 | DE-627 | ||
005 | 20231226070839.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12985-023-02042-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1188.xml |
035 | |a (DE-627)NLM356620034 | ||
035 | |a (NLM)37158904 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wei, Shanchen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Predictive values of procalcitonin for coinfections in patients with COVID-19 |b a systematic review and meta-analysis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.05.2023 | ||
500 | |a Date Revised 20.06.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a OBJECTIVES: To assess the ability of procalcitonin (PCT)-a promising marker for coinfections-to predict coinfections in patients with COVID-19 | ||
520 | |a METHODS: In this systematic review and meta-analysis, PubMed, Embase, Web of Science, Cochrane, the China National Knowledge Infrastructure (CNKI), and Wanfang were searched to identify eligible studies (up to August 30, 2021). Articles that reported the predictive value of PCT for coinfections in patients with COVID-19 were included. Individual and pooled sensitivities and specificities were reported, and I2 was used to test heterogeneity. This study was prospectively registered on the International Prospective Register of Systematic Reviews (PROSPERO) database (registration number: CRD42021283344) | ||
520 | |a RESULTS: Five studies involving a total of 2775 patients reported the predictive value of PCT for coinfections in patients with COVID-19. The sensitivity, specificity, and area under the curve of PCT in predicting coinfections in the pooled studies were 0.60 (95% CI 0.35-0.81, I2 = 88.85), 0.71 (95% CI 0.58-0.81, I2 = 87.82), and 0.72(95% CI 0.68-0.76) respectively | ||
520 | |a CONCLUSIONS: Although PCT has limited predictive value for coinfections in patients with COVID-19, lower PCT levels seem to indicate a decreased probability of having a coinfection | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Coinfections | |
650 | 4 | |a Meta-analysis | |
650 | 4 | |a Predictive | |
650 | 4 | |a Procalcitonin | |
650 | 7 | |a Procalcitonin |2 NLM | |
700 | 1 | |a Wang, Lina |e verfasserin |4 aut | |
700 | 1 | |a Lin, Lianjun |e verfasserin |4 aut | |
700 | 1 | |a Liu, Xinmin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Virology journal |d 2004 |g 20(2023), 1 vom: 08. Mai, Seite 92 |w (DE-627)NLM151772509 |x 1743-422X |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2023 |g number:1 |g day:08 |g month:05 |g pages:92 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12985-023-02042-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2023 |e 1 |b 08 |c 05 |h 92 |